Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 90051-90100 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05246579
Prospective Evaluation of Pathways for Preterm Birth
N/ARecruiting
240 participants
Started: Feb 4, 2022 · Completed: Jun 1, 2026
2 conditions1 sponsor1 location
NCT05198791
Stratified Medicine of Eplerenone in Acute MI/injury (StratMed-MINOCA)
PHASE2Recruiting
350 participants
Started: Feb 4, 2022 · Completed: Jul 31, 2026
3 conditions3 sponsors2 locations
NCT04797767
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
PHASE1/PHASE2Recruiting
62 participants
Started: Feb 4, 2022 · Completed: Dec 31, 2027
13 conditions2 sponsors1 location
NCT05410015
Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Ovarian Cancer
N/ARecruiting
300 participants
Started: Feb 3, 2022 · Completed: Feb 3, 2026
1 condition1 sponsor1 location
NCT05220189
PENK Methylation Test for Detecting Bladder Cancer
N/ARecruiting
1,549 participants
Started: Feb 3, 2022 · Completed: Jan 31, 2024
2 conditions11 sponsors1 location
NCT05366140
Thoracic-Lumbar Arthrodesis- Implanet Jazz
N/ARecruiting
300 participants
Started: Feb 3, 2022 · Completed: Sep 30, 2032
3 conditions2 sponsors1 location
NCT04594746
Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study
PHASE4Recruiting
42 participants
Started: Feb 3, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05446779
Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death
N/AActive, not recruiting
400 participants
Started: Feb 3, 2022 · Completed: Dec 31, 2026
4 conditions5 sponsors1 location
NCT05064709
Assessment of CCM in HF With Higher Ejection Fraction
NARecruiting
1,500 participants
Started: Feb 3, 2022 · Completed: Feb 1, 2029
5 conditions1 sponsor105 locations
NCT05089227
Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study
PHASE2Recruiting
72 participants
Started: Feb 3, 2022 · Completed: Aug 31, 2028
3 conditions1 sponsor1 location
NCT05149638
Updated Diagnostic Cortisol Values for Adrenal Insufficiency
NARecruiting
90 participants
Started: Feb 3, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05239000
A Study Comparing Geriatric Co-Management With Geriatric Guided Supportive Care in Older Patients Receiving Chemoradiation Therapy for Their Head and Neck Cancer
NAActive, not recruiting
30 participants
Started: Feb 3, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor6 locations
NCT05220319
CORTERAS STUDY: The Effect of Corticosteroids on Early Recovery After Major Surgery in Elderly Patients
PHASE4Recruiting
672 participants
Started: Feb 3, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05173987
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)
PHASE3Active, not recruiting
280 participants
Started: Feb 3, 2022 · Completed: May 27, 2027
1 condition3 sponsors195 locations
NCT04754191
Enfortumab Vedotin as Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
PHASE2Recruiting
34 participants
Started: Feb 3, 2022 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT05016505
Supporting Smoke-Free Policy Compliance in Public Housing
NAActive, not recruiting
512 participants
Started: Feb 3, 2022 · Completed: Nov 30, 2025
4 conditions2 sponsors1 location
NCT04840342
MR Antagonist and LSD1
PHASE4Recruiting
300 participants
Started: Feb 3, 2022 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT04661059
Study of Late-foetal Human Organ Development
N/ARecruiting
2,000 participants
Started: Feb 3, 2022 · Completed: Dec 31, 2040
1 condition1 sponsor1 location
NCT05076617
A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
PHASE3Enrolling by invitation
300 participants
Started: Feb 3, 2022 · Completed: Nov 30, 2028
1 condition1 sponsor140 locations
NCT04655885
Cardiac Output Optimization on Postoperative Complications in Major Hepatic Surgery
NARecruiting
186 participants
Started: Feb 3, 2022 · Completed: May 15, 2026
1 condition1 sponsor1 location
NCT05230550
Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use) With Sogroya®
N/AEnrolling by invitation
200 participants
Started: Feb 3, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor47 locations
NCT05172921
Environmental Factors and Thyroid Cancer
N/ARecruiting
500 participants
Started: Feb 3, 2022 · Completed: Sep 30, 2035
1 condition1 sponsor1 location
NCT06570356
Assessment of Depression Levels in Elderly Patients With an Orthopedic Fracture Compared to Patients After a Stroke.
NAActive, not recruiting
400 participants
Started: Feb 2, 2022 · Completed: Nov 13, 2024
4 conditions1 sponsor1 location
NCT04895995
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
NARecruiting
95 participants
Started: Feb 2, 2022 · Completed: Mar 15, 2026
4 conditions1 sponsor1 location
NCT05162651
Effect of Extended Cannabis Abstinence on PTSD Symptoms
NARecruiting
24 participants
Started: Feb 2, 2022 · Completed: Sep 1, 2024
4 conditions1 sponsor1 location
NCT06149676
A Novel Probiotic-antibiotic Combination to Prevent Recurrent Urinary Tract Infections
EARLY_PHASE1Recruiting
35 participants
Started: Feb 2, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04472702
Fluoroscopic Versus Ultrasound Guidance for Cooled Radiofrequency Ablation of Geniculate Nerves in Knee Osteoarthritis: A Randomized Control Trial
NARecruiting
90 participants
Started: Feb 2, 2022 · Completed: Oct 1, 2025
1 condition2 sponsors2 locations
NCT05138588
Personalized Repetitive Transcranial Magnetic Stimulation (rTMS) in Cognitive Fluctuations of Dementia With Lewy Bodies (DLB): Proof of Concept
NARecruiting
40 participants
Started: Feb 2, 2022 · Completed: Jul 31, 2028
2 conditions1 sponsor1 location
NCT04507178
Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine
PHASE2Recruiting
100 participants
Started: Feb 2, 2022 · Completed: Apr 1, 2027
2 conditions1 sponsor1 location
NCT05204888
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
NARecruiting
642 participants
Started: Feb 2, 2022 · Completed: Mar 31, 2027
1 condition2 sponsors27 locations
NCT04442061
Autism Spectrum Disorders: Double Blind Randomized Placebo-control Active Pilot Study of Transcranial Magnetic Stimulation Applied to the Superior Temporal Sulcus
PHASE2Recruiting
20 participants
Started: Feb 2, 2022 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT05113186
Neoadjuvant and Adjuvant Lenvatinib in HCC Patients Treated by Percutaneous Ablative
PHASE2Active, not recruiting
32 participants
Started: Feb 2, 2022 · Completed: Oct 2, 2026
1 condition2 sponsors1 location
NCT04896775
NiteCAPP: Web-based Interventions for Insomnia in Rural Dementia Caregivers
NARecruiting
100 participants
Started: Feb 2, 2022 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT05070845
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
PHASE2Recruiting
61 participants
Started: Feb 2, 2022 · Completed: Oct 1, 2027
1 condition1 sponsor28 locations
NCT05252702
Aveir DR i2i Study
NAActive, not recruiting
464 participants
Started: Feb 2, 2022 · Completed: Nov 30, 2025
3 conditions1 sponsor78 locations
NCT03240211
Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL
PHASE1Active, not recruiting
37 participants
Started: Feb 2, 2022 · Completed: May 25, 2026
2 conditions3 sponsors2 locations
NCT04945369
"Follow-up During the Peripubertal Period of Preterm Children Included in the Protocol Entitled EPIPOD."
NARecruiting
114 participants
Started: Feb 2, 2022 · Completed: Feb 2, 2028
1 condition1 sponsor1 location
NCT05063162
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD)
PHASE3Recruiting
104 participants
Started: Feb 2, 2022 · Completed: Jul 1, 2027
1 condition1 sponsor80 locations
NCT05156866
First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer
PHASE1Recruiting
70 participants
Started: Feb 2, 2022 · Completed: Feb 15, 2027
4 conditions2 sponsors12 locations
NCT04794127
Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone.
PHASE2Recruiting
10 participants
Started: Feb 2, 2022 · Completed: Feb 2, 2025
3 conditions3 sponsors1 location
NCT05304351
Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older
PHASE2Active, not recruiting
1,516 participants
Started: Feb 2, 2022 · Completed: Mar 6, 2032
2 conditions1 sponsor14 locations
NCT06025006
Impact of an Alternative to Incarceration by Housing and Support by Assertive Community Treatment Team for Homeless People With Severe Psychiatric Disorders Referred to Immediate Referral Procedure: AILSI Program
NARecruiting
220 participants
Started: Feb 2, 2022 · Completed: Aug 2, 2026
1 condition1 sponsor1 location
NCT04271878
Hypercapnia and Orthostatic Tolerance in Postural Orthostatic Tachycardia Syndrome
NARecruiting
26 participants
Started: Feb 2, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05159999
The Home Blood Pressure (BP) Trial
NAActive, not recruiting
200 participants
Started: Feb 2, 2022 · Completed: Apr 30, 2026
1 condition3 sponsors2 locations
NCT05146726
Patient Blood Management Charité (PBM-Charité): Structured Detection, Differentiated Diagnostics and Therapy of Preoperative Anemia and Use of Machine Autotransfusion in Elective Interventions
N/ARecruiting
2,700 participants
Started: Feb 2, 2022 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT04971850
Sleep-disordered Breathing and Neurocognitive Assessment in Children and Young Adults
NARecruiting
1,200 participants
Started: Feb 2, 2022 · Completed: Feb 29, 2028
1 condition2 sponsors1 location
NCT04840589
Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors
PHASE1Recruiting
66 participants
Started: Feb 2, 2022 · Completed: Jan 1, 2026
4 conditions1 sponsor9 locations
NCT05363345
Comparison of Vortic Catch V Basket Catheter and Ordinary Basket Catheter for the Removal of Bile Duct Stones
NARecruiting
100 participants
Started: Feb 2, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05183984
Niraparib with BeVAcizumab After Complete CytoreductioN in Patients with OvArian Cancer
PHASE2Recruiting
390 participants
Started: Feb 1, 2022 · Completed: Feb 28, 2030
1 condition1 sponsor87 locations
NCT05898035
Postoperative Symptoms Following Endodontic Microsurgery
NARecruiting
40 participants
Started: Feb 1, 2022 · Completed: Sep 30, 2025
2 conditions2 sponsors1 location